A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity

By afschroeder • May 21, 2026

Esquenazi A, Wein TH, Verduzco-Gutierrez M, Ayyoub Z, Page S, Harding S, Maisonobe P, Beneteau M, Patel A; DIRECTION study group. A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity. Adv Ther. 2026 May 20. doi: 10.1007/s12325-026-03635-y. Epub ahead of print. PMID: 42159955.

Tags: AbobotulinumtoxinA, Crossover study, General Internal Medicine, Head-to-head double-blind study, OnabotulinumtoxinA, Physical Medicine & Rehabilitation, Publications, safety, Upper limb spasticity

Effects of Age on Inflammatory Bowel Disease Presentation and Management in Older Adults

Sisliyan C, Andres JT, Keyashian K. Effects of Age on Inflammatory Bowel Disease Presentation and Management in Older Adults. Dig Dis Sci. 2026 Aug 9.[...]

Staff Perspectives on Optimising Organisational Responses to Patient-Initiated Workplace Violence

Cannedy S, Lesser R, Yano EM, Hamilton AB, Fenwick KM. Staff Perspectives on Optimising Organisational Responses to Patient-Initiated Workplace Violence. J Adv Nurs. 2026 Aug[...]

Effectiveness and safety of rituximab-pvvr versus originator rituximab for rheumatoid arthritis in the veterans health administration

Ghassemi S, Singh JA, Jiang R, Young-Xu Y, Cunningham FE, Glassman PA, Zhao X, Salone C, Au A, Miller DR, Her Q, Dong D, Aspinall[...]